514 related articles for article (PubMed ID: 8615464)
1. The effect of intravenous erythromycin on esophageal motility in healthy subjects.
Tzovaras G; Xynos E; Chrysos E; Mantides A; Vassilakis JS
Am J Surg; 1996 Mar; 171(3):316-9. PubMed ID: 8615464
[TBL] [Abstract][Full Text] [Related]
2. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
Koutsoumbi P; Epanomeritakis E; Tsiaoussis J; Athanasakis H; Chrysos E; Zoras O; Vassilakis JS; Xynos E
Am J Gastroenterol; 2000 Dec; 95(12):3388-92. PubMed ID: 11151866
[TBL] [Abstract][Full Text] [Related]
3. Deterioration of esophageal motility with age: a manometric study of 79 healthy subjects.
Grande L; Lacima G; Ros E; Pera M; Ascaso C; Visa J; Pera C
Am J Gastroenterol; 1999 Jul; 94(7):1795-801. PubMed ID: 10406237
[TBL] [Abstract][Full Text] [Related]
4. Erythromycin, motilin, and the esophagus.
Pennathur A; Cioppi M; Fayad JB; Little AG
Surgery; 1993 Aug; 114(2):295-8; discussion 298-9. PubMed ID: 8342132
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium valproate on esophageal motility in healthy subjects and patients with gastroesophageal reflux.
Tzovaras G; Tsiaoussis J; Athanasakis E; Zoras O; Xynos E; Chrysos E
Scand J Gastroenterol; 2004 Jun; 39(6):521-6. PubMed ID: 15223674
[TBL] [Abstract][Full Text] [Related]
6. Endogenous nitric oxide in the control of esophageal motility in humans.
Konturek JW; Thor P; Lukaszyk A; Gabryelewicz A; Konturek SJ; Domschke W
J Physiol Pharmacol; 1997 Jun; 48(2):201-9. PubMed ID: 9223025
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous midazolam on esophageal motility testing in normal human volunteers.
Marsh JK; Hoffman SM; Dmuchowski CF
Am J Gastroenterol; 1993 Jun; 88(6):860-3. PubMed ID: 8503381
[TBL] [Abstract][Full Text] [Related]
8. The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults.
Rhee PL; Hyun JG; Lee JH; Kim YH; Son HJ; Kim JJ; Paik SW; Rhee JC; Choi KW
Am J Gastroenterol; 2001 Dec; 96(12):3251-7. PubMed ID: 11774933
[TBL] [Abstract][Full Text] [Related]
9. Metoclopramide effect on esophageal peristalsis in normal human volunteers.
DiPalma JA; Perucca PJ; Martin DF; Pierson WP; Meyer GW
Am J Gastroenterol; 1987 Apr; 82(4):307-10. PubMed ID: 3565333
[TBL] [Abstract][Full Text] [Related]
10. Comparison of esophageal manometric characteristics in asymptomatic subjects and symptomatic patients with high-amplitude esophageal peristaltic contractions.
Traube M; McCallum RW
Am J Gastroenterol; 1987 Sep; 82(9):831-5. PubMed ID: 3631028
[TBL] [Abstract][Full Text] [Related]
11. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
[TBL] [Abstract][Full Text] [Related]
12. Segmental high amplitude peristaltic contractions in the distal esophagus.
Freidin N; Mittal RK; Traube M; McCallum RW
Am J Gastroenterol; 1989 Jun; 84(6):619-23. PubMed ID: 2729233
[TBL] [Abstract][Full Text] [Related]
13. Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers.
Di Stefano M; Papathanasopoulos A; Blondeau K; Vos R; Boecxstaens V; Farré R; Rommel N; Tack J
Dis Esophagus; 2012 Jul; 25(5):470-6. PubMed ID: 22050410
[TBL] [Abstract][Full Text] [Related]
14. Double blind placebo controlled study on the effect of the nitric oxide donor molsidomin and the 5-HT3 antagonist ondansetron on human esophageal motility.
Willis S; Allescher HD; Stoschus B; Schusdziarra V; Classen M; Schumpelick V
Z Gastroenterol; 1994 Nov; 32(11):632-6. PubMed ID: 7886971
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease.
Pennathur A; Tran A; Cioppi M; Fayad J; Sieren GL; Little AG
Am J Surg; 1994 Jan; 167(1):169-72; discussion 172-3. PubMed ID: 8311129
[TBL] [Abstract][Full Text] [Related]
16. Patterns of esophageal inhibition during swallowing, pharyngeal stimulation, and transient LES relaxation. Lower esophageal sphincter.
Pouderoux P; Verdier E; Kahrilas PJ
Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G242-7. PubMed ID: 12388187
[TBL] [Abstract][Full Text] [Related]
17. The effect of pirenzepine on esophageal motility.
Erckenbrecht E; Berges W; Sonnenberg A; Erckenbrecht J; Wienbeck M
Scand J Gastroenterol Suppl; 1982; 72():185-90. PubMed ID: 6957989
[TBL] [Abstract][Full Text] [Related]
18. [The lower esophageal sphincter in patients with Chagas' disease with peristalsis and aperistalsis].
Dantas RO; de Godoy RA
Arq Gastroenterol; 1983; 20(1):13-6. PubMed ID: 6414443
[TBL] [Abstract][Full Text] [Related]
19. Effect of doses of glucagon used to treat food impaction on esophageal motor function of normal subjects.
Colon V; Grade A; Pulliam G; Johnson C; Fass R
Dysphagia; 1999; 14(1):27-30. PubMed ID: 9828271
[TBL] [Abstract][Full Text] [Related]
20. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
